Data / Form D filings / Axelyf, Inc.
Axelyf, Inc.: Form D filing
Axelyf, Inc., a biotechnology company in Chestnut Hill, MA, filed a Form D with the SEC in 2026. The latest, on October 13, 2026, reports $2.6 million sold of a $2.7 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 33 Glenland Road Unit 2, Chestnut Hill, MA, 02467
- Phone
- (508) 494-0155
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2078406
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 13 | New notice | $2,700,000 | $2,631,439 | $68,561 | 8 | Oct 7 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Orn Almarsson | Executive Officer, Director, Promoter | |
| Leslie Williams | Director | |
| Arni Blondal | Director |
Other biotechnology companies in Massachusetts that filed recently
- LeanBio Therapeutics, Inc. offering · Oct 22
- Quiver Holdings Inc. $3 million · Oct 21
- BIOVENTRIX, INC. $1.2 million · Oct 8
- Opus KSD, Inc. $680,801 · Oct 1
Every Form D from the week of Oct 12 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Axelyf, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.